YM281 是一种有效的 EZH2 抑制剂,可诱导细胞凋亡 (apoptosis) 和 G0/G1 期细胞周期停滞,在体内显示出抗肿瘤作用,并具有研究淋巴瘤的潜力。
产品编号: MS-I92125 CAS No.: 2230914-84-6 分子式: C56H71N7O9S 分子量: 1018.27
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
50mg
询价
询价
100mg
询价
询价
250mg
询价
询价

产品描述

YM281 是一种有效的 EZH2 抑制剂,可诱导细胞凋亡 (apoptosis) 和 G0/G1 期细胞周期停滞,在体内显示出抗肿瘤作用,并具有研究淋巴瘤的潜力。

生物实验数据

生物活性 YM281 is a potent EZH2 inhibitor that induces apoptosis and G0/G1 cell cycle arrest, exhibits antitumor effects in vivo, and has potential for lymphoma research.
体外研究
(In Vitro)

YM281 (compound V2) (0-6 µM; 0-48 h) decreases the EZH2 protein level and the PRC2 (polycomb repressive complex 2) complex through the VHL (vonHippel−Lindau)-dependent ubiquitin-proteasome system.
YM281 (0-10 µM; 24 h) shows anticancer effects in lymphoma cells.
YM281 (0-5 µM) induces cell apoptosis and cell cycle arrest at the G0/G1 phase.
YM281 (0-5 µM; 24 h) increases the activity of caspase-3 and -7 and meanwhile reduces the cell viability in primary lymphoma cells.

Western Blot Analysis

Cell Line: SU-DHL-2, 22Rv1 cells
Concentration: 0-6 µM
Incubation Time: 0-48 h
Result: Abrogated both the EZH2 protein level and the H3K27me3 degree in a concentration-dependent manner in 24 h, had no significant effect on the protein level of EZH1,and significantly increased the expression of EZH2 ubiquitination.

Cell Viability Assay

Cell Line: SU-DHL-2, SU-DHL-4, SU-DHL-6 cells
Concentration: 0-10 µM
Incubation Time: 24 h
Result: Induced nearly complete cell viability inhibition.

Cell Cycle Analysis

Cell Line: SU-DHL-6 cells
Concentration: 1, 3, 5 µM
Incubation Time: 24 h
Result: Induced cell cycle arrest at the G0/G1 phase and a profound sub-G1 population increasein a concentration-dependent manner.

Apoptosis Analysis

Cell Line: SU-DHL-6 cells
Concentration: 0-5 µM
Incubation Time: 48 h
Result: Significantly increased the expression of cleaved caspase-3 and PARP.
体内研究
(In Vivo)

YM281 (80, 100 mg/kg; i.v.; 6 times for 3 weeks) shows antitumor effects and significantly reduces the expression of EZH2 protein and H3K27me3 levels.

Animal Model: Balb/c nude mice (SU-DHL-6 xenograft model)
Dosage: 80 mg/kg
Administration: I.v.; 6 times for 3 weeks
Result: Remarkably suppressed the tumor volume and significantly reduced the EZH2 protein and H3K27me3 levels.
Animal Model: Balb/c nude mice (Jeko-1 xenograft model)
Dosage: 100 mg/kg
Administration: I.v.; 6 times for 3 weeks
Result: Shows anti-tumor effects with the significantly reduced the expression of EZH2 protein and H3K27me3 levels.

化学信息

分子量 1018.27
分子式 C56H71N7O9S
CAS No. 2230914-84-6

储存&溶解度

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础